Humana partners with Heal to reach patients where they live

Humana is sinking $100 million into a primary care startup to send doctors into patients’ homes via 1-touch telemed or old-school housecalls.

The startup, Heal, announced the partnership July 29, saying it has delivered more than 200,000 value-based home visits in its first five years.

Along with tele-primary care, the company offers telepsychology and digital monitoring services to patients in New York, New Jersey, Washington, California, Georgia, Virginia, Maryland and Washington, D.C.

The collaboration will focus on expanding the companies’ reach to Chicago, Charlotte, Houston and other areas.

Heal says having Humana as a partner will “make it easier for those who are healthy and aging into Medicare as well as those living with multiple chronic conditions to receive primary care in the comfort of their own homes.”

Humana’s home-business president, Susan Diamond, says the partnership will advance its ongoing efforts to “build a broader set of offerings across the spectrum of home-based care.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.